Today’s Solutions: November 02, 2024

In 2020, Oregon voted to become the first state to legalize access to psilocybin for all adults. A study reinforces the idea that voters made a sensible decision.

The preliminary human trials investigated the effect of psilocybin-assisted psychotherapy to treat the major depressive disorder (MDD). It is estimated that some 300 million people worldwide suffer from the debilitating condition. While a larger Phase 2 trial testing psilocybin for MDD is currently underway, this study offers the first peer-reviewed published data showing efficacy for this particular mental health condition.

For the trials, a total of 24 subjects were recruited with at least two-years documented history of depression, with all subjects being required to wean off any anti-depressant treatment before the trial commenced. As reported in NewAtlas, depression was assessed using the standard GRID-Hamilton Depression Rating Scale. Severe depression scores 24 or higher on the scale, while seven or less is classified as no depression. At the beginning of the study, the average score for the cohort was 23.

The treatment process resembled the general protocol used in most psilocybin studies. Two doses of psilocybin were administered to each subject, spaced two weeks apart. A number of psychotherapy sessions both preceded and followed the active psilocybin sessions.

By the end of the study, 71 percent of the cohort displayed more than a 50 percent reduction in depressive symptoms after four weeks. A month later, the average depression score was done from 23 to 8, and more than half of the group were considered to be in remission. In comparison with studies focusing on the efficacy of antidepressants on MDD, psilocybin therapy was four times more effective.

Of course, the study itself isn’t without limitations. 24 subjects is a small sample size, and there was no placebo control. However, with a larger Phase 2 trial already underway, to collect even more accurate data on the therapeutic impact of psilocybin therapy.

Source study: JAMA Psychiatry – Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

Solutions News Source Print this article
More of Today's Solutions

This heartwarming Danish ad breaks down the ‘Us vs Them’ narrative

It’s rare that we publish a story about an advertisement, but then again it’s rare that an ad stirs so much emotion within its ...

Read More

NOAHs: Charlotte has a formula for long-lasting affordable housing

We recently shared how empty retail space could be the solution to California’s affordable housing crisis. Across the country in North Carolina, the city ...

Read More

A seat at the table for underrepresented communities

Climate change is already affecting all of us—however, those that bear the brunt of these consequences are predominantly from low-income, marginalized, BIPOC communities. So ...

Read More

Expanding democracy: Michigan opens new doors for formerly incarcerated voters

Malijah Gee's path from incarceration at the age of 17 to imminent freedom reflects the longing for a voice that has been suppressed for 36 years. ...

Read More